A0005 Time-dependent survival benefit of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: Reconstructed analysis of the PEACE-3 trial

European Urology 2026

View at publisher

Authors: W. Chen, S. Yoshida, S. Yajima, K. Tanabe, M. Fujiwara, H. Fukushima, H. Tanaka, A. Hirakawa, H. Masuda, Y. Fujii

DOI: 10.1016/s0302-2838(26)00073-4

Cited by: 0

Fields of Study & Subjects

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Bone health and treatments